medigraphic.com
ISSN 2448-8909 (Print)

2019, Number 6

<< Back Next >>

Med Crit 2019; 33 (6)

Brain venous thrombosis in the unit of neurological intensive care of the National Institute of Neurology and Neurosurgery

García CU, Gracia VJJ, Juárez DG, Cruz PJ, Becerra HI

Language: Spanish
References: 24
Page: 305-310
PDF size: 236.90 Kb.


ABSTRACT

Cerebral venous thrombosis (TVC) is a potentially devastating state that occurs in young adults, especially women. Less frequent subtype of cerebral vascular disease (EVC), represented only 0.5% in EVC patients. Headache is the most common symptom common. It requires an accurate diagnosis since the pathophysiology and treatment differ from the arterial EVC. The understanding of the risk factors is the key to the prognosis of the TVC.
Objective: To determine the prevalence, the main clinical, radiological findings and prognosis of TVC in Neurological Intensive Care Unit.
Material and methods: Retrospective, longitudinal and analytical study of an observational nature. All patients admitted to the Neurological Intensive Care Unit of the National Institute of Neurology and Neurosurgery (INNN) with the diagnosis of TVC from January 2010 to July 2019 confirmed by venous phase computed tomography (vein CT) and/or vein were considered MRI (vein MRI), which will have clinical information and cabinet studies, as well as, the evolution, treatment and prognosis at hospital discharge.
Results: Of a total of 14 patients, with an average age of 33 years of age. Of which 85.72% (n = 12) were women and 14.28 (n = 2) were men. Headache occurred 50% of cases. The main predisposing cause for TVC was the use of oral contraceptives in 6 patients (42.85%) and puerperium in three patients (21.42%). The delay in diagnosis was an average of 48 hours. The imaging method used for diagnosis in 64.28% of those with computed tomography in venous phase and in 37.71% with vein magnetic resonance. The upper longitudinal sinus was the most affected in 50% of cases. The average stay in the Intensive Care Unit (ICU) was seven days, where 100% of patients received anticoagulation. Three patients (21.4%) developed intracranial hypertension who underwent decompressive craniectomy between the second and fifth day of stay. The days of mechanical ventilation on average were seven days. With an average hospital stay of 20 days. Mortality at hospital discharge was 21.42%.
Conclusions: TVC is less frequent than ischemic stroke or intracerebral hemorrhage. The spectrum of the clinic is broad, with pivotal headache. The confirmation of the diagnosis must be performed with CT vein and/or RM vein. The therapeutic intervention within the acute phase is aimed at the recanalization of the thrombosed sinus or sinuses and the prevention of complications; anticoagulation with low molecular weight heparin is the first-line treatment, which has shown an impact on the prognosis of patients. We must keep in mind that thrombolysis and thrombectomy are an option in treatment. In the case of decompressive craniectomy, it is indicated only in cases of malignant venous infarctions. The results after TVC are generally favorable, they also depend on the patient’s factors, such as sex and the specific risk factors of women.


REFERENCES

  1. Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis. Continuum (Minneap Minn). 2014;20(2 Cerebrovascular Disease):335-351.

  2. Rodríguez-Rubio LR, Medina-Córdova LL, Andrade-Ramos MA, González-Padilla C, Bañuelos-Becerra LJ, Chiquete E, et al. Trombosis venosa cerebral en el Hospital Civil de Guadalajara “Fray Antonio Alcalde”. Rev Mex Neuroci. 2009;10(3):177-183.

  3. Özdemir HH, Varol S, Akıl E, Acar A, Demir CF. Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents. Neurol Sci. 2015;36(1):149-153.

  4. Bousser MG, Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res. 2012;130 Suppl 1:S19-S22.

  5. Radaković B, Goldstajn MS. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome. Coll Antropol. 2007;31(3):919-921.

  6. Dmytriw AA, Song JSA, Yu E, Poon CS. Cerebral venous thrombosis: state of the art diagnosis and management. Neuroradiology. 2018;60(7):669-685.

  7. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162-170.

  8. Chiewvit P, Piyapittayanan S, Poungvarin N. Cerebral venous thrombosis: diagnosis dilemma. Neurol Int. 2011;3(3):e13.

  9. Walecki J, Mruk B, Nawrocka-Laskus E, Piliszek A, Przelaskowski A, Sklinda K. Neuroimaging of cerebral venous thrombosis (CVT) - old dilemma and the new diagnostic methods. Pol J Radiol. 2015;80:368-373.

  10. Roland T, Jacobs J, Rappaport A, Vanheste R, Wilms G, Demaerel P. Unenhanced brain CT is useful to decide on further imaging in suspected venous sinus thrombosis. Clin Radiol. 2010;65(1):34-39.

  11. Meckel S, Reisinger C, Bremerich J, Damm D, Wolbers M, Engelter S, et al. Cerebral venous thrombosis: diagnostic accuracy of combined, dynamic and static, contrast-enhanced 4D MR venography. AJNR Am J Neuroradiol. 2010;31(3):527-535.

  12. Hedderich DM, Ferro JM, Kunz WG. Diagnostic imaging in the management of patients with possible cerebral venous thrombosis: a cost-effectiveness analysis. Neuroradiology. 2019;61(10):1155-1163.

  13. Izura-Gómez M, Misis Del Campo M, Puyalto de Pablo P, Castaño-Duque C. Mechanical thrombectomy: an alternative for treating cerebral venous sinus thrombosis. Emergencias. 2018;30(2):123-125.

  14. Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost. 2015;13 Suppl 1:S238-S44.

  15. Verhagen MJ, van Es AC, Lycklama À Nijeholt GJ, Jellema K, Coutinho J, van den Wijngaard IR. Successful mechanical thrombectomy in a comatose patient with cerebral venous sinus thrombosis: a case report. Interv Neuroradiol. 2017;23(4):437-440.

  16. Pizzi MA, Alejos DA, Siegel JL, Kim BY, Miller DA, Freeman WD. Cerebral venous thrombosis associated with intracranial hemorrhage and timing of anticoagulation after hemicraniectomy. J Stroke Cerebrovasc Dis. 2016;25(9):2312-2316.

  17. Omoto K, Nakagawa I, Park HS, Wada T, Motoyama Y, Kichikawa K, et al. Successful emergent endovascular mechanical thrombectomy for pediatric and young adult cerebral venous sinus thrombosis in coma. World Neurosurg. 2019;122:203-208.

  18. Cabral de Andrade G, Lesczynsky A, Clímaco VM, Pereira ER, Marcelino PO, Franco A, et al. Cerebral venous sinuses thrombosis in both transverse sinus and torcula: Multistep endovascular treatment and stenting. Interv Neuroradiol. 2017;23(1):84-89.

  19. Kumar S, Rajshekher G, Reddy CR, Venkateswarlu J, Prabhakar S. Intrasinus thrombolysis in cerebral venous sinus thrombosis: single-center experience in 19 patients. Neurol India. 2010;58(2):225-229.

  20. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39(4):1152-1158.

  21. Nasr DM, Brinjikji W, Cloft HJ, Saposnik G, Rabinstein AA. Mortality in cerebral venous thrombosis: results from the national inpatient sample database. Cerebrovasc Dis. 2013;35(1):40-44.

  22. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-1192.

  23. Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17(10):1229-1235.

  24. Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Bousser MG, Stam J; ISCVT Investigators. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41(11):2575-2580.




2020     |     www.medigraphic.com